Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2025

May 22, 2025

33018_dirs_2025-05-22_01997e07-73ba-4c30-b294-07d9989078cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2025-05-20

Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-20 Stock Option (Right to Buy) $34.96 A 53491 Acquired 2035-05-20 Common Stock (53491) Direct

Footnotes

F1: The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.